3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
7
Completed
4
Unknown
3
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
8
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Breast Neoplasms
630
Prostatic Neoplasms
372
Neoplasms
305
Carcinoma, Non-Small-Cell Lung
215
Lung Neoplasms
204
Colorectal Neoplasms
176
Multiple Myeloma
143
Pancreatic Neoplasms
136
Leukemia, Myeloid, Acute
128
Neoplasm Metastasis
124
Brain Neoplasms
117
Melanoma
116
Ovarian Neoplasms
101
Carcinoma, Hepatocellular
101
Precursor Cell Lymphoblastic Leukemia-Lymphoma
100
Glioblastoma
99
Uterine Cervical Neoplasms
97
Head and Neck Neoplasms
94
Squamous Cell Carcinoma of Head and Neck
93
Colonic Neoplasms
82
Stomach Neoplasms
80
Recurrence
80
Rectal Neoplasms
80
Urinary Bladder Neoplasms
77
Sarcoma
77
Carcinoma, Renal Cell
76
Triple Negative Breast Neoplasms
75
Lymphoma
71
Lymphoma, Non-Hodgkin
67
Leukemia, Lymphocytic, Chronic, B-Cell
66
Interventions
Paclitaxel
2
Carboplatin
2
atezolizumab
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
OTHER
×
Respiratory Tract Neoplasms
×
Clear all
NCT04564157
2026-05-05
NADIM-ADJUVANT
Fundación GECP
Phase 3
Active not recruiting
210 enrolled
NCT04776447
2025-04-09
APOLO
Fundación GECP
Phase 2
Active not recruiting
38 enrolled